US Market
About scPharmaceuticals Inc
This company creates and commercialises products that lower healthcare costs and improve health outcomes. They develop these products themselves or through partnerships to enhance outpatient care for specific acute conditions. Their main product in development, FUROSCIX, involves a formulation of furosemide delivered through a wearable device for the treatment of edema in adults with conditions like congestive heart failure, liver cirrhosis and renal disease. Other products in their pipeline include scCeftriaxone and scCarbapenem, both antibiotics for intravenous use in treating infections caused by certain bacteria.
Freetrade is your gateway to commission-free investing. Join over 1.6 million users using the Best online trading platform, as voted at the British Bank Awards for six years running.
Freetrade does not provide investment advice and individual investors should make their own decisions or seek independent advice. The value of investments can go down as well as up and you may receive back less than your original investment. Past performance is not a reliable indicator of future returns. Freetrade is a trading name of Freetrade Limited, which is a member firm of the London Stock Exchange and is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales (no. 09797821).
© 2025 Freetrade, All rights reserved. The Apple logo is a trademark of Apple Inc. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.